Related Experiment Videos
Urinary albumin excretion. An independent predictor of ischemic heart disease
K Borch-Johnsen1, B Feldt-Rasmussen, S Strandgaard
1Centre of Preventive Medicine, Glostrup University Hospital, Glostrup Denmark. kbjo@novo.dk
Insights
Microalbuminuria, indicated by a high urinary albumin-to-creatinine ratio, independently predicts ischemic heart disease (IHD). This marker significantly amplifies the risk associated with traditional cardiovascular risk factors.
Area of Science:
- Cardiology
- Nephrology
- Epidemiology
Background:
- Cross-sectional studies link increased urinary albumin excretion to cardiovascular disease, dyslipidemia, and hypertension.
- The predictive value of urinary albumin-to-creatinine (A/C) ratio for ischemic heart disease (IHD) in the general population requires prospective investigation.
Purpose of the Study:
- To prospectively evaluate the urinary albumin-to-creatinine (A/C) ratio as an independent predictor of ischemic heart disease (IHD).
Main Methods:
- A population-based cohort of 2085 participants without IHD, renal disease, UTI, or diabetes was established in 1983.
- Urinary albumin and creatinine levels, conventional atherosclerotic risk factors were measured.
- Participants were followed for IHD development until 1993, with IHD defined by specific ICD codes.
Main Results:
- Microalbuminuria (A/C ratio > 90th percentile) was identified in a subset of participants.
- Adjusted analysis revealed microalbuminuria as an independent predictor of IHD, with a relative risk of 2.3 (95% CI, 1.3 to 3.9; P=0.002).
- Microalbuminuria presence decreased 10-year disease-free survival from 97% to 91% (P<0.0001) and interacted with smoking to amplify IHD risk.
Conclusions:
- Microalbuminuria is an independent predictor of ischemic heart disease (IHD) in the general population.
- Microalbuminuria significantly enhances the predictive power of established atherosclerotic risk factors for IHD.
- The urinary albumin-to-creatinine ratio is a valuable biomarker for cardiovascular risk stratification.
Abstract:
Cross-sectional studies suggest that an increased urinary albumin excretion rate is associated with cardiovascular disease, dyslipidemia, and hypertension. The purpose of this study was to analyze prospectively whether the urinary albumin-to -creatinine (A/C) ratio can independently predict ischemic heart disease (IHD) in a population-based cohort. In 1983, urinary albumin and creatinine levels were measured, along with the conventional atherosclerotic risk factors, in 2085 consecutive participants without IHD, renal disease, urinary tract infection, or diabetes mellitus. The participants were followed up until death, emigration, or December 31, 1993. IHD was defined as a hospital discharge diagnosis or cause of death including the diagnoses ICD-8 and 410 to 414. Seventy-nine individuals developed IHD during the 21 130 person-years of follow-up. They were characterized by a preponderance of males and higher age, body mass index, blood pressure, lipoproteins, and proportion of current smokers. Microalbuminuria was defined as an A/C ratio) >90 percentile (>0.65 mg/mmol). When adjusted for other risk factors, the relative risk of IHD associated with microalbuminuria was 2.3 (95% CI, 1.3 to 3.9, P=0.002), and the 10-year disease-free survival decreased from 97% to 91% (P<0.0001) when microalbuminuria was present. An interaction between microalbuminuria and smoking was observed, and the presence of microalbuminuria more than doubled the predictive effect of the conventional atherosclerotic risk factors for development of IHD. It is concluded that microalbuminuria is not only an independent predictor of IHD but also substantially increases the risk associated with other established risk factors.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Diabetic Nephropathy
Nephrotic Syndrome II : Assessment and Medical Management
Urine Studies I: Urinalysis
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate